The international BIO convention is all about seduction. All fifty states sent representatives to Philly this week to make the case that their state was the best for biotech. Seventy countries were there touting their awesome awesomeness. Does all this seduction really work? A new class of drugs for cardiovascular disease was reviewed recently at the FDA. Will they become blockbusters like Pfizer’s Lipitor?
Share this post
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.